FC vs PG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Franklin Covey exhibits severe financial fragility, highlighted by a critical Piotroski F-Score of 2/9, indicating weak operational health. While the company maintains a very low debt-to-equity ratio (0.02), it suffers from a significant liquidity crisis with a current ratio of 0.63 and a quick ratio of 0.42. Stagnant revenue growth (0.10% YoY) and a disastrous recent earnings track record—missing 4 of the last 4 estimates with an average surprise of -82.73%—suggest a failing business model or a difficult transition. Despite a low Price-to-Sales ratio, the combination of negative profit margins and a bearish technical trend (10/100) outweighs the analyst target price.
PG exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is severely overvalued relative to its deterministic baselines. The current price of $145.71 represents a massive premium over the Graham Number ($58.45) and Intrinsic Value ($47.25), while a PEG ratio of 3.92 indicates the valuation is disconnected from its stagnant growth. Negative earnings growth (-5.40% YoY) combined with bearish insider activity and a 0/100 technical trend suggests significant downside risk despite the company's operational efficiency.
Compare Another Pair
Related Comparisons
FC vs PG: Head-to-Head Comparison
This page compares Franklin Covey Co. (FC) and The Procter & Gamble Company (PG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.